PMN - ProMIS Neurosciences Inc. Common Shares (ON)

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.47 0.01 (1.64%)	---	0.0 (0.0%)	0.0 (0.0%)	0.01 (2.35%)	-0.02 (-4.17%)	0.01 (1.97%)	0.01 (1.97%)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.21
Diluted EPS:: -0.21
Basic P/E:: -2.27
Diluted P/E:: -2.27
RSI(14) 1m:: 100.0
VWAP:: 0.48
RVol:: 0.7758

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.46 -0.01 (-1.39%)	Oct 15 15:59
10m	Price decrease 10m	0.46 -0.02 (-3.38%)	Oct 15 15:38
1m	Price decrease 1m	0.46 -0.01 (-2.79%)	Oct 15 15:38
1m	Price decrease 1m	0.47 -0.01 (-1.11%)	Oct 15 14:16
1m	Price decrease 1m	0.47 -0.01 (-1.28%)	Oct 15 13:17